

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 9.36926402 |
| 2 | chemical homeostasis within a tissue (GO:0048875) | 7.83189970 |
| 3 | detection of molecule of bacterial origin (GO:0032490) | 7.28829554 |
| 4 | auditory receptor cell stereocilium organization (GO:0060088) | 6.71562659 |
| 5 | cellular anion homeostasis (GO:0030002) | 6.69110977 |
| 6 | negative regulation of macroautophagy (GO:0016242) | 6.59271834 |
| 7 | trivalent inorganic anion homeostasis (GO:0072506) | 6.31543829 |
| 8 | phosphate ion homeostasis (GO:0055062) | 6.31543829 |
| 9 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.97153050 |
| 10 | energy homeostasis (GO:0097009) | 5.48665512 |
| 11 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.29869472 |
| 12 | sarcomere organization (GO:0045214) | 5.10811471 |
| 13 | keratinization (GO:0031424) | 5.06382132 |
| 14 | post-embryonic morphogenesis (GO:0009886) | 4.93822170 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.81390059 |
| 16 | cardiac myofibril assembly (GO:0055003) | 4.78474501 |
| 17 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.65951152 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.56243888 |
| 19 | negative regulation of meiosis (GO:0045835) | 4.49064204 |
| 20 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.47879330 |
| 21 | inner ear receptor stereocilium organization (GO:0060122) | 4.47423982 |
| 22 | cardiac muscle contraction (GO:0060048) | 4.43561744 |
| 23 | myofibril assembly (GO:0030239) | 4.41524568 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.33645220 |
| 25 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.33426192 |
| 26 | cardiac muscle hypertrophy (GO:0003300) | 4.33213977 |
| 27 | pattern specification involved in kidney development (GO:0061004) | 4.29931695 |
| 28 | establishment of skin barrier (GO:0061436) | 4.22379927 |
| 29 | actin-myosin filament sliding (GO:0033275) | 4.15591981 |
| 30 | muscle filament sliding (GO:0030049) | 4.15591981 |
| 31 | striated muscle hypertrophy (GO:0014897) | 4.06424257 |
| 32 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.02372364 |
| 33 | regulation of actin filament-based movement (GO:1903115) | 3.96149758 |
| 34 | positive regulation of neurological system process (GO:0031646) | 3.93083292 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.92834825 |
| 36 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.91907858 |
| 37 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.83918466 |
| 38 | lateral ventricle development (GO:0021670) | 3.82768878 |
| 39 | regulation of water loss via skin (GO:0033561) | 3.78394717 |
| 40 | atrioventricular valve morphogenesis (GO:0003181) | 3.76468760 |
| 41 | prostate gland growth (GO:0060736) | 3.73817675 |
| 42 | muscle hypertrophy (GO:0014896) | 3.72408288 |
| 43 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.72368657 |
| 44 | forebrain neuron differentiation (GO:0021879) | 3.71898434 |
| 45 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.71545634 |
| 46 | cell communication involved in cardiac conduction (GO:0086065) | 3.67593872 |
| 47 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.65376248 |
| 48 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.62208946 |
| 49 | regulation of cardioblast differentiation (GO:0051890) | 3.61491693 |
| 50 | actomyosin structure organization (GO:0031032) | 3.60335212 |
| 51 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.56418303 |
| 52 | glycoside metabolic process (GO:0016137) | 3.55580355 |
| 53 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.54510335 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.42497609 |
| 55 | positive regulation of p38MAPK cascade (GO:1900745) | 3.41783834 |
| 56 | actin-mediated cell contraction (GO:0070252) | 3.40419974 |
| 57 | multicellular organismal water homeostasis (GO:0050891) | 3.37266821 |
| 58 | striated muscle contraction (GO:0006941) | 3.36299687 |
| 59 | neuron remodeling (GO:0016322) | 3.34307717 |
| 60 | regulation of sarcomere organization (GO:0060297) | 3.28506105 |
| 61 | negative regulation of complement activation (GO:0045916) | 3.25387784 |
| 62 | regulation of the force of heart contraction (GO:0002026) | 3.24785613 |
| 63 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.24218895 |
| 64 | epithelial structure maintenance (GO:0010669) | 3.23337701 |
| 65 | muscle tissue morphogenesis (GO:0060415) | 3.22453432 |
| 66 | striated muscle atrophy (GO:0014891) | 3.20998599 |
| 67 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.19985089 |
| 68 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.19434069 |
| 69 | sphingosine metabolic process (GO:0006670) | 3.16705472 |
| 70 | negative regulation of response to extracellular stimulus (GO:0032105) | 3.14812586 |
| 71 | negative regulation of response to nutrient levels (GO:0032108) | 3.14812586 |
| 72 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.12529522 |
| 73 | response to inactivity (GO:0014854) | 3.11324336 |
| 74 | skeletal muscle adaptation (GO:0043501) | 3.08955566 |
| 75 | regulation of striated muscle contraction (GO:0006942) | 3.08345064 |
| 76 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.05204335 |
| 77 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.04709754 |
| 78 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.04210649 |
| 79 | keratinocyte differentiation (GO:0030216) | 3.02951657 |
| 80 | negative regulation of protein localization to cell surface (GO:2000009) | 2.99027403 |
| 81 | regulation of relaxation of muscle (GO:1901077) | 2.98600137 |
| 82 | actin filament-based movement (GO:0030048) | 2.98253635 |
| 83 | negative regulation of meiotic cell cycle (GO:0051447) | 2.97222627 |
| 84 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.96950598 |
| 85 | cardiac muscle adaptation (GO:0014887) | 2.96802449 |
| 86 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.96802449 |
| 87 | muscle hypertrophy in response to stress (GO:0003299) | 2.96802449 |
| 88 | cardiac muscle cell action potential (GO:0086001) | 2.96615277 |
| 89 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.95885458 |
| 90 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.95885458 |
| 91 | regulation of p38MAPK cascade (GO:1900744) | 2.94763625 |
| 92 | regulation of activation of Janus kinase activity (GO:0010533) | 2.94190675 |
| 93 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.94119028 |
| 94 | estrogen biosynthetic process (GO:0006703) | 2.92415716 |
| 95 | diol metabolic process (GO:0034311) | 2.91602685 |
| 96 | cellular response to epinephrine stimulus (GO:0071872) | 2.89954043 |
| 97 | positive regulation of vascular permeability (GO:0043117) | 2.89378815 |
| 98 | water homeostasis (GO:0030104) | 2.86047129 |
| 99 | muscle atrophy (GO:0014889) | 2.86028590 |
| 100 | striated muscle adaptation (GO:0014888) | 2.84698870 |
| 101 | negative regulation of protein activation cascade (GO:2000258) | 2.82783081 |
| 102 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.81532685 |
| 103 | exogenous drug catabolic process (GO:0042738) | 2.80685120 |
| 104 | adult heart development (GO:0007512) | 2.78337823 |
| 105 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.77795684 |
| 106 | heart contraction (GO:0060047) | 2.77633402 |
| 107 | heart process (GO:0003015) | 2.77633402 |
| 108 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.75879992 |
| 109 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.75823648 |
| 110 | cell proliferation involved in kidney development (GO:0072111) | 2.75689805 |
| 111 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.74390291 |
| 112 | regulation of heart rate (GO:0002027) | 2.73744228 |
| 113 | potassium ion export (GO:0071435) | 2.72105294 |
| 114 | negative regulation of mast cell activation (GO:0033004) | 2.71801336 |
| 115 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.71560888 |
| 116 | cardiac conduction (GO:0061337) | 2.70049488 |
| 117 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.69750783 |
| 118 | relaxation of cardiac muscle (GO:0055119) | 2.68588501 |
| 119 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.66819477 |
| 120 | cell communication by electrical coupling (GO:0010644) | 2.64871213 |
| 121 | regulation of cardiac muscle contraction (GO:0055117) | 2.64684824 |
| 122 | peptide cross-linking (GO:0018149) | 2.63583955 |
| 123 | response to epinephrine (GO:0071871) | 2.63574074 |
| 124 | sphingoid metabolic process (GO:0046519) | 2.63110610 |
| 125 | response to caffeine (GO:0031000) | 2.62158830 |
| 126 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.61559546 |
| 127 | muscle adaptation (GO:0043500) | 2.61500318 |
| 128 | endocardial cushion development (GO:0003197) | 2.61279717 |
| 129 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60785702 |
| 130 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.60780205 |
| 131 | cellular response to reactive nitrogen species (GO:1902170) | 2.60268037 |
| 132 | regulation of heart contraction (GO:0008016) | 2.60057694 |
| 133 | macrophage activation (GO:0042116) | 2.59529584 |
| 134 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.58116476 |
| 135 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.57258635 |
| 136 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.56705582 |
| 137 | mesenchymal cell proliferation (GO:0010463) | 2.56146281 |
| 138 | regulation of membrane repolarization (GO:0060306) | 2.55366875 |
| 139 | negative regulation of cell fate specification (GO:0009996) | 2.52223474 |
| 140 | negative regulation of humoral immune response (GO:0002921) | 2.52051451 |
| 141 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.50232514 |
| 142 | positive regulation of protein kinase C signaling (GO:0090037) | 2.49685147 |
| 143 | detection of calcium ion (GO:0005513) | 2.49407200 |
| 144 | ganglion development (GO:0061548) | 2.49300262 |
| 145 | negative regulation of myotube differentiation (GO:0010832) | 2.48728475 |
| 146 | epidermal cell differentiation (GO:0009913) | 2.48574378 |
| 147 | regulation of necroptotic process (GO:0060544) | 2.47696910 |
| 148 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47132253 |
| 149 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.46671414 |
| 150 | lung secretory cell differentiation (GO:0061140) | 2.46181427 |
| 151 | somatic stem cell division (GO:0048103) | 2.45963259 |
| 152 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.42727686 |
| 153 | germinal center formation (GO:0002467) | 2.39765026 |
| 154 | vocalization behavior (GO:0071625) | 2.38079314 |
| 155 | negative regulation of glial cell proliferation (GO:0060253) | 2.35518556 |
| 156 | lung lobe morphogenesis (GO:0060463) | 2.34834747 |
| 157 | opioid receptor signaling pathway (GO:0038003) | 2.32337568 |
| 158 | positive regulation of protein sumoylation (GO:0033235) | 2.30874953 |
| 159 | pigment granule localization (GO:0051875) | 2.29239283 |
| 160 | positive regulation of histone acetylation (GO:0035066) | 2.29067910 |
| 161 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.28684587 |
| 162 | cell proliferation involved in metanephros development (GO:0072203) | 2.28363210 |
| 163 | mesonephros development (GO:0001823) | 2.27700318 |
| 164 | positive regulation of neurotransmitter transport (GO:0051590) | 2.27368063 |
| 165 | drug catabolic process (GO:0042737) | 2.26350078 |
| 166 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.25483654 |
| 167 | positive regulation of protein homooligomerization (GO:0032464) | 2.23711032 |
| 168 | response to pheromone (GO:0019236) | 2.23263711 |
| 169 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.22935707 |
| 170 | O-glycan processing (GO:0016266) | 2.22601215 |
| 171 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.21776363 |
| 172 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.20842733 |
| 173 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.18269321 |
| 174 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.17155179 |
| 175 | tachykinin receptor signaling pathway (GO:0007217) | 2.15541412 |
| 176 | branch elongation of an epithelium (GO:0060602) | 2.15133724 |
| 177 | negative regulation of autophagy (GO:0010507) | 2.14053471 |
| 178 | regulation of phospholipase A2 activity (GO:0032429) | 2.13264953 |
| 179 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.12926309 |
| 180 | negative regulation of stem cell proliferation (GO:2000647) | 2.12684946 |
| 181 | regulation of glomerular filtration (GO:0003093) | 2.11732594 |
| 182 | pigment granule transport (GO:0051904) | 2.10892480 |
| 183 | regulation of chemokine secretion (GO:0090196) | 2.10314675 |
| 184 | regulation of glial cell proliferation (GO:0060251) | 2.10133410 |
| 185 | regulation of meiosis (GO:0040020) | 2.09896778 |
| 186 | desmosome organization (GO:0002934) | 2.09404647 |
| 187 | motile cilium assembly (GO:0044458) | 2.08411912 |
| 188 | venous blood vessel morphogenesis (GO:0048845) | 2.08118179 |
| 189 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.07636096 |
| 190 | sodium-independent organic anion transport (GO:0043252) | 2.06249204 |
| 191 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.03793209 |
| 192 | eye photoreceptor cell development (GO:0042462) | 2.03708291 |
| 193 | polyketide metabolic process (GO:0030638) | 18.3196669 |
| 194 | doxorubicin metabolic process (GO:0044598) | 18.3196669 |
| 195 | daunorubicin metabolic process (GO:0044597) | 18.3196669 |
| 196 | aminoglycoside antibiotic metabolic process (GO:0030647) | 11.7759074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.36820400 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22098194 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16513553 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.10263470 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.04895247 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.92636672 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71362322 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.45445647 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.35930968 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.18253760 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16494064 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.04916134 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.03566003 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.97833458 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.97833458 |
| 16 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.95363516 |
| 17 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.95363516 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94058454 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89291171 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87718112 |
| 21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86998471 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85609800 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.81061063 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.80078558 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79790571 |
| 26 | RXR_22108803_ChIP-Seq_LS180_Human | 1.79440520 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78009641 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.77941623 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.74421837 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74310937 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.72966861 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72822338 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.70651643 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.70473477 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.66368124 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65166361 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61069878 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60984483 |
| 39 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.57812301 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57720527 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57673609 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.57060641 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57039044 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.56957202 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54805412 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53935387 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53656417 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53473869 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53048067 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52354290 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.51712340 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51576994 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51274948 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49868228 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46715049 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45615024 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45038131 |
| 58 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.44902680 |
| 59 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43027659 |
| 60 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42619778 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.39970883 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39382619 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38104888 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37321292 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36917633 |
| 66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35847402 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35773848 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34836772 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34316197 |
| 70 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34246680 |
| 71 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33900537 |
| 72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31746321 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31069463 |
| 74 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30764972 |
| 75 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29946771 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29580980 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29386226 |
| 78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29000519 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28886689 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.27692001 |
| 81 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27689157 |
| 82 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.27326089 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26513568 |
| 84 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.25695287 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.25347266 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24668494 |
| 87 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24046216 |
| 88 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24046216 |
| 89 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23169333 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22958857 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21279198 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20860097 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20562086 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20495175 |
| 95 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18303190 |
| 96 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17414279 |
| 97 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17360997 |
| 98 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15779806 |
| 99 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.15725641 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15645164 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15548778 |
| 102 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.14598145 |
| 103 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14049561 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13686461 |
| 105 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13015779 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12571658 |
| 107 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12426276 |
| 108 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12070059 |
| 109 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11099265 |
| 110 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10173612 |
| 111 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09064068 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09017176 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07396607 |
| 114 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.07335466 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06883890 |
| 116 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06481330 |
| 117 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06146593 |
| 118 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06028671 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05451036 |
| 120 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04641403 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04045261 |
| 122 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04029876 |
| 123 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03862364 |
| 124 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03701089 |
| 125 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03551926 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03438979 |
| 127 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02987476 |
| 128 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.02804044 |
| 129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02691379 |
| 130 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01521704 |
| 131 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01011674 |
| 132 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00083186 |
| 133 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99824351 |
| 134 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99303814 |
| 135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99118622 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99118622 |
| 137 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99002409 |
| 138 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98454478 |
| 139 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97955867 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97859377 |
| 141 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97715184 |
| 142 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95424160 |
| 143 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95370630 |
| 144 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94953970 |
| 145 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94927509 |
| 146 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94620798 |
| 147 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94282753 |
| 148 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93045675 |
| 149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92752607 |
| 150 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92125013 |
| 151 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90194582 |
| 152 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87691327 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85793298 |
| 154 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84935202 |
| 155 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83566725 |
| 156 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83558637 |
| 157 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83509250 |
| 158 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83341225 |
| 159 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.83127761 |
| 160 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82895188 |
| 161 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82658134 |
| 162 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82281360 |
| 163 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80957465 |
| 164 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80398932 |
| 165 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79179852 |
| 166 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78734995 |
| 167 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77069173 |
| 168 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76726712 |
| 169 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76399003 |
| 170 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76247818 |
| 171 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76247109 |
| 172 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76126703 |
| 173 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76038024 |
| 174 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.75640338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 6.63203106 |
| 2 | MP0003878_abnormal_ear_physiology | 6.19071523 |
| 3 | MP0005377_hearing/vestibular/ear_phenot | 6.19071523 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.90520308 |
| 5 | * MP0008004_abnormal_stomach_pH | 4.61061464 |
| 6 | MP0000566_synostosis | 4.36223920 |
| 7 | MP0004510_myositis | 3.74800146 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.57960848 |
| 9 | MP0005645_abnormal_hypothalamus_physiol | 3.47602486 |
| 10 | MP0004215_abnormal_myocardial_fiber | 3.38905300 |
| 11 | MP0004036_abnormal_muscle_relaxation | 3.26075361 |
| 12 | MP0005275_abnormal_skin_tensile | 3.22028383 |
| 13 | MP0008995_early_reproductive_senescence | 3.17655367 |
| 14 | MP0000678_abnormal_parathyroid_gland | 3.15687252 |
| 15 | MP0003879_abnormal_hair_cell | 2.87515414 |
| 16 | MP0000751_myopathy | 2.73107363 |
| 17 | MP0005083_abnormal_biliary_tract | 2.60653074 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.55920296 |
| 19 | MP0005330_cardiomyopathy | 2.55532092 |
| 20 | MP0009697_abnormal_copulation | 2.49257078 |
| 21 | MP0004742_abnormal_vestibular_system | 2.48612709 |
| 22 | MP0006292_abnormal_olfactory_placode | 2.31138277 |
| 23 | MP0002972_abnormal_cardiac_muscle | 2.15104921 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 2.05273649 |
| 25 | MP0001958_emphysema | 2.02934367 |
| 26 | MP0004484_altered_response_of | 2.00460277 |
| 27 | MP0003303_peritoneal_inflammation | 1.98995944 |
| 28 | MP0008775_abnormal_heart_ventricle | 1.98612682 |
| 29 | MP0003941_abnormal_skin_development | 1.96508598 |
| 30 | MP0006138_congestive_heart_failure | 1.95996905 |
| 31 | MP0001177_atelectasis | 1.93519324 |
| 32 | MP0003137_abnormal_impulse_conducting | 1.92825642 |
| 33 | MP0002132_abnormal_respiratory_system | 1.88779007 |
| 34 | MP0002098_abnormal_vibrissa_morphology | 1.83531643 |
| 35 | MP0004087_abnormal_muscle_fiber | 1.82587701 |
| 36 | MP0005165_increased_susceptibility_to | 1.82472730 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.81867978 |
| 38 | MP0001346_abnormal_lacrimal_gland | 1.79819182 |
| 39 | MP0010630_abnormal_cardiac_muscle | 1.77441156 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.74416355 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.70225576 |
| 42 | MP0003828_pulmonary_edema | 1.68898919 |
| 43 | MP0005670_abnormal_white_adipose | 1.64298023 |
| 44 | MP0003724_increased_susceptibility_to | 1.63535471 |
| 45 | * MP0001664_abnormal_digestion | 1.62286583 |
| 46 | MP0009840_abnormal_foam_cell | 1.62109454 |
| 47 | MP0005620_abnormal_muscle_contractility | 1.62100581 |
| 48 | MP0004085_abnormal_heartbeat | 1.61744282 |
| 49 | MP0000681_abnormal_thyroid_gland | 1.60534240 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.56330437 |
| 51 | MP0000749_muscle_degeneration | 1.56271015 |
| 52 | MP0000343_altered_response_to | 1.55626523 |
| 53 | * MP0000470_abnormal_stomach_morphology | 1.50275843 |
| 54 | MP0005385_cardiovascular_system_phenoty | 1.49893394 |
| 55 | MP0001544_abnormal_cardiovascular_syste | 1.49893394 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.49356802 |
| 57 | MP0004947_skin_inflammation | 1.39865584 |
| 58 | MP0005451_abnormal_body_composition | 1.39713413 |
| 59 | MP0000579_abnormal_nail_morphology | 1.39576813 |
| 60 | MP0002102_abnormal_ear_morphology | 1.37726590 |
| 61 | MP0002133_abnormal_respiratory_system | 1.33653085 |
| 62 | MP0005388_respiratory_system_phenotype | 1.33653085 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.30806517 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.29254191 |
| 65 | MP0003091_abnormal_cell_migration | 1.28829530 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.28757352 |
| 67 | MP0005248_abnormal_Harderian_gland | 1.28149329 |
| 68 | MP0002796_impaired_skin_barrier | 1.27482204 |
| 69 | MP0005367_renal/urinary_system_phenotyp | 1.26797419 |
| 70 | MP0000516_abnormal_urinary_system | 1.26797419 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.26517379 |
| 72 | MP0005666_abnormal_adipose_tissue | 1.26100432 |
| 73 | MP0008438_abnormal_cutaneous_collagen | 1.24728328 |
| 74 | MP0005647_abnormal_sex_gland | 1.20966729 |
| 75 | MP0005023_abnormal_wound_healing | 1.19265772 |
| 76 | MP0002127_abnormal_cardiovascular_syste | 1.18599351 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.17397466 |
| 78 | MP0003279_aneurysm | 1.17154947 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.16560774 |
| 80 | MP0000747_muscle_weakness | 1.15586641 |
| 81 | MP0001440_abnormal_grooming_behavior | 1.14338533 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 1.12869245 |
| 83 | MP0002106_abnormal_muscle_physiology | 1.11345154 |
| 84 | MP0002269_muscular_atrophy | 1.10575932 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.10561607 |
| 86 | MP0005423_abnormal_somatic_nervous | 1.10105847 |
| 87 | MP0000383_abnormal_hair_follicle | 1.07423804 |
| 88 | MP0005310_abnormal_salivary_gland | 1.06535098 |
| 89 | MP0004043_abnormal_pH_regulation | 1.04364015 |
| 90 | MP0003646_muscle_fatigue | 1.01638791 |
| 91 | MP0010368_abnormal_lymphatic_system | 1.00805938 |
| 92 | MP0002557_abnormal_social/conspecific_i | 0.96346143 |
| 93 | MP0002060_abnormal_skin_morphology | 0.96137918 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.95693420 |
| 95 | MP0000627_abnormal_mammary_gland | 0.95382144 |
| 96 | MP0003786_premature_aging | 0.94079630 |
| 97 | MP0005369_muscle_phenotype | 0.92853747 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.92490446 |
| 99 | MP0002249_abnormal_larynx_morphology | 0.91332264 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.90894618 |
| 101 | MP0004130_abnormal_muscle_cell | 0.90538117 |
| 102 | MP0005164_abnormal_response_to | 0.88495555 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 0.87585447 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.86775980 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.85877351 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.84630991 |
| 107 | MP0001919_abnormal_reproductive_system | 0.83332979 |
| 108 | MP0000750_abnormal_muscle_regeneration | 0.82635584 |
| 109 | MP0002933_joint_inflammation | 0.82007461 |
| 110 | MP0005503_abnormal_tendon_morphology | 0.81766546 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.80497934 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.80455465 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.80380524 |
| 114 | MP0005166_decreased_susceptibility_to | 0.80278852 |
| 115 | MP0001486_abnormal_startle_reflex | 0.80258708 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.78709387 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.78709387 |
| 118 | MP0001542_abnormal_bone_strength | 0.78590086 |
| 119 | MP0000762_abnormal_tongue_morphology | 0.78158661 |
| 120 | MP0010155_abnormal_intestine_physiology | 0.78109457 |
| 121 | MP0001881_abnormal_mammary_gland | 0.77598364 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.77013334 |
| 123 | MP0009278_abnormal_bone_marrow | 0.76209873 |
| 124 | MP0001501_abnormal_sleep_pattern | 0.75746751 |
| 125 | MP0003436_decreased_susceptibility_to | 0.75593885 |
| 126 | MP0000249_abnormal_blood_vessel | 0.74892806 |
| 127 | MP0002938_white_spotting | 0.74628480 |
| 128 | MP0000631_abnormal_neuroendocrine_gland | 0.74156591 |
| 129 | MP0002148_abnormal_hypersensitivity_rea | 0.74143508 |
| 130 | MP0009785_altered_susceptibility_to | 0.73700516 |
| 131 | MP0001502_abnormal_circadian_rhythm | 0.73419522 |
| 132 | MP0000639_abnormal_adrenal_gland | 0.71345201 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.71298726 |
| 134 | MP0004858_abnormal_nervous_system | 0.69462535 |
| 135 | MP0002877_abnormal_melanocyte_morpholog | 0.69194976 |
| 136 | MP0003690_abnormal_glial_cell | 0.69073446 |
| 137 | MP0001175_abnormal_lung_morphology | 0.68775198 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.68268225 |
| 139 | MP0005595_abnormal_vascular_smooth | 0.68096618 |
| 140 | MP0005025_abnormal_response_to | 0.67978720 |
| 141 | MP0000026_abnormal_inner_ear | 0.67935339 |
| 142 | MP0002638_abnormal_pupillary_reflex | 0.67838278 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.66395027 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.66372754 |
| 145 | MP0003566_abnormal_cell_adhesion | 0.65902945 |
| 146 | MP0003045_fibrosis | 0.65238002 |
| 147 | MP0003868_abnormal_feces_composition | 0.64946058 |
| 148 | MP0004885_abnormal_endolymph | 0.64768251 |
| 149 | MP0005501_abnormal_skin_physiology | 0.64020114 |
| 150 | MP0003937_abnormal_limbs/digits/tail_de | 0.60947438 |
| 151 | MP0003890_abnormal_embryonic-extraembry | 0.60689953 |
| 152 | MP0001879_abnormal_lymphatic_vessel | 0.57882858 |
| 153 | MP0002233_abnormal_nose_morphology | 0.57390729 |
| 154 | MP0001324_abnormal_eye_pigmentation | 0.57064207 |
| 155 | MP0000537_abnormal_urethra_morphology | 0.56402859 |
| 156 | MP0001293_anophthalmia | 0.55834100 |
| 157 | MP0003936_abnormal_reproductive_system | 0.54894073 |
| 158 | MP0000613_abnormal_salivary_gland | 0.54623116 |
| 159 | MP0002736_abnormal_nociception_after | 0.53931730 |
| 160 | MP0001851_eye_inflammation | 0.53923771 |
| 161 | MP0001790_abnormal_immune_system | 0.53642747 |
| 162 | MP0005387_immune_system_phenotype | 0.53642747 |
| 163 | MP0009764_decreased_sensitivity_to | 0.53587128 |
| 164 | MP0001119_abnormal_female_reproductive | 0.53041694 |
| 165 | MP0005389_reproductive_system_phenotype | 0.53024335 |
| 166 | MP0004883_abnormal_blood_vessel | 0.52732380 |
| 167 | MP0001968_abnormal_touch/_nociception | 0.52708240 |
| 168 | MP0005167_abnormal_blood-brain_barrier | 0.51764440 |
| 169 | MP0000534_abnormal_ureter_morphology | 0.50922732 |
| 170 | MP0001666_abnormal_nutrient_absorption | 0.50657836 |
| 171 | MP0005171_absent_coat_pigmentation | 0.50644364 |
| 172 | MP0003385_abnormal_body_wall | 0.48729189 |
| 173 | MP0002998_abnormal_bone_remodeling | 0.48491956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 8.41709298 |
| 2 | Unilateral renal agenesis (HP:0000122) | 7.40822481 |
| 3 | Alopecia of scalp (HP:0002293) | 7.32260160 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 7.13618301 |
| 5 | Sudden death (HP:0001699) | 6.52816441 |
| 6 | Follicular hyperkeratosis (HP:0007502) | 6.49575209 |
| 7 | Bilateral sensorineural hearing impairment (HP:0008619) | 6.39713910 |
| 8 | Interstitial pulmonary disease (HP:0006530) | 5.85574712 |
| 9 | Absent eyebrow (HP:0002223) | 5.73504223 |
| 10 | Abnormality of dental color (HP:0011073) | 5.71251104 |
| 11 | Ventricular tachycardia (HP:0004756) | 5.53121407 |
| 12 | Recurrent corneal erosions (HP:0000495) | 5.08399633 |
| 13 | Chronic otitis media (HP:0000389) | 5.01471574 |
| 14 | Absent eyelashes (HP:0000561) | 4.99216564 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 4.98970648 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.98970648 |
| 17 | Bundle branch block (HP:0011710) | 4.97124881 |
| 18 | Atrial fibrillation (HP:0005110) | 4.88744233 |
| 19 | Syncope (HP:0001279) | 4.74031182 |
| 20 | Cheilitis (HP:0100825) | 4.58060841 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 4.42989778 |
| 22 | Hyporeflexia of lower limbs (HP:0002600) | 4.21901485 |
| 23 | Supraventricular tachycardia (HP:0004755) | 4.20246877 |
| 24 | Increased IgE level (HP:0003212) | 4.18782412 |
| 25 | Tetany (HP:0001281) | 4.14632923 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 4.08377547 |
| 27 | Supraventricular arrhythmia (HP:0005115) | 4.07992548 |
| 28 | Hyperphosphatemia (HP:0002905) | 4.05649675 |
| 29 | Abolished electroretinogram (ERG) (HP:0000550) | 3.83296546 |
| 30 | Ventricular fibrillation (HP:0001663) | 3.82144505 |
| 31 | Abnormality of nail color (HP:0100643) | 3.81917767 |
| 32 | Tubulointerstitial fibrosis (HP:0005576) | 3.77280551 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.76241716 |
| 34 | Muscle fiber splitting (HP:0003555) | 3.75444774 |
| 35 | Abnormal ciliary motility (HP:0012262) | 3.73041756 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 3.67221420 |
| 37 | Distal lower limb muscle weakness (HP:0009053) | 3.58873269 |
| 38 | Lipoatrophy (HP:0100578) | 3.52158863 |
| 39 | Dilated cardiomyopathy (HP:0001644) | 3.45432380 |
| 40 | Ectropion (HP:0000656) | 3.44560220 |
| 41 | Erythroderma (HP:0001019) | 3.27269825 |
| 42 | Tubulointerstitial nephritis (HP:0001970) | 3.23020384 |
| 43 | Renal dysplasia (HP:0000110) | 3.19293328 |
| 44 | Abnormality of the fingertips (HP:0001211) | 3.13997737 |
| 45 | Heart block (HP:0012722) | 3.11925043 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 3.11247323 |
| 47 | Exercise-induced myalgia (HP:0003738) | 3.10272458 |
| 48 | Congenital sensorineural hearing impairment (HP:0008527) | 3.08035289 |
| 49 | Blepharitis (HP:0000498) | 3.06018822 |
| 50 | Palmoplantar keratoderma (HP:0000982) | 3.04684082 |
| 51 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.04578741 |
| 52 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.04578741 |
| 53 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.01769299 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.85834011 |
| 55 | Plantar hyperkeratosis (HP:0007556) | 2.83687185 |
| 56 | Respiratory distress (HP:0002098) | 2.83086806 |
| 57 | Atrioventricular block (HP:0001678) | 2.78463169 |
| 58 | Abnormality of the calf musculature (HP:0001430) | 2.74537878 |
| 59 | Prolonged QT interval (HP:0001657) | 2.73520762 |
| 60 | Palmoplantar hyperkeratosis (HP:0000972) | 2.70998232 |
| 61 | Corneal erosion (HP:0200020) | 2.70019849 |
| 62 | Onycholysis (HP:0001806) | 2.69695607 |
| 63 | Abnormality of incisor morphology (HP:0011063) | 2.68320453 |
| 64 | Rhinitis (HP:0012384) | 2.67492228 |
| 65 | Tachypnea (HP:0002789) | 2.67096115 |
| 66 | Chronic hepatic failure (HP:0100626) | 2.63192025 |
| 67 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.62831287 |
| 68 | Complement deficiency (HP:0004431) | 2.62667747 |
| 69 | Tubulointerstitial abnormality (HP:0001969) | 2.62509659 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 2.62096053 |
| 71 | EMG: myopathic abnormalities (HP:0003458) | 2.61815277 |
| 72 | Absent hair (HP:0002298) | 2.58916617 |
| 73 | Neoplasm of the lung (HP:0100526) | 2.56416176 |
| 74 | Palmar hyperkeratosis (HP:0010765) | 2.55708351 |
| 75 | Chronic sinusitis (HP:0011109) | 2.55613777 |
| 76 | Glomerulonephritis (HP:0000099) | 2.54193564 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.51606724 |
| 78 | Hyperaldosteronism (HP:0000859) | 2.47492589 |
| 79 | Abnormality of chloride homeostasis (HP:0011422) | 2.46301594 |
| 80 | Increased connective tissue (HP:0009025) | 2.46167993 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.40825040 |
| 82 | Nuclear cataract (HP:0100018) | 2.39975626 |
| 83 | Thyroid-stimulating hormone excess (HP:0002925) | 2.35444687 |
| 84 | Keratitis (HP:0000491) | 2.33740674 |
| 85 | Sudden cardiac death (HP:0001645) | 2.31819338 |
| 86 | Tubular atrophy (HP:0000092) | 2.28508879 |
| 87 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.26285887 |
| 88 | Abnormal EKG (HP:0003115) | 2.24353549 |
| 89 | Hyperkalemia (HP:0002153) | 2.21146096 |
| 90 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20575592 |
| 91 | Osteomalacia (HP:0002749) | 2.20287586 |
| 92 | Amelogenesis imperfecta (HP:0000705) | 2.17425213 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16747767 |
| 94 | Dysmetric saccades (HP:0000641) | 2.15946409 |
| 95 | Cerebral aneurysm (HP:0004944) | 2.15584320 |
| 96 | Renal salt wasting (HP:0000127) | 2.14475961 |
| 97 | Septo-optic dysplasia (HP:0100842) | 2.10771077 |
| 98 | Neoplasm of the respiratory system (HP:0100606) | 2.10309863 |
| 99 | Abnormality of complement system (HP:0005339) | 2.09160573 |
| 100 | Chronic bronchitis (HP:0004469) | 2.07801726 |
| 101 | Aneurysm (HP:0002617) | 2.07665996 |
| 102 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.07351229 |
| 103 | Subaortic stenosis (HP:0001682) | 2.07351229 |
| 104 | Neck muscle weakness (HP:0000467) | 2.06372517 |
| 105 | Conical tooth (HP:0000698) | 2.05999531 |
| 106 | Type 1 muscle fiber predominance (HP:0003803) | 2.05623226 |
| 107 | Ulnar bowing (HP:0003031) | 2.05454971 |
| 108 | Palpitations (HP:0001962) | 2.03154426 |
| 109 | Abnormality of the right ventricle (HP:0001707) | 2.02238068 |
| 110 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01923282 |
| 111 | Gangrene (HP:0100758) | 2.01512546 |
| 112 | Calf muscle hypertrophy (HP:0008981) | 1.99499623 |
| 113 | Malnutrition (HP:0004395) | 1.98881339 |
| 114 | Lower limb amyotrophy (HP:0007210) | 1.98853487 |
| 115 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.97689117 |
| 116 | Genetic anticipation (HP:0003743) | 1.96365801 |
| 117 | Hypergonadotropic hypogonadism (HP:0000815) | 1.95137024 |
| 118 | Abnormality of the renal collecting system (HP:0004742) | 1.94530082 |
| 119 | Bile duct proliferation (HP:0001408) | 1.93142844 |
| 120 | Abnormal biliary tract physiology (HP:0012439) | 1.93142844 |
| 121 | Ectopic kidney (HP:0000086) | 1.91520701 |
| 122 | Abnormality of the salivary glands (HP:0010286) | 1.91210808 |
| 123 | Thick nail (HP:0001805) | 1.90758448 |
| 124 | Renal agenesis (HP:0000104) | 1.90318002 |
| 125 | Gout (HP:0001997) | 1.89879914 |
| 126 | Frequent falls (HP:0002359) | 1.88515964 |
| 127 | Duplicated collecting system (HP:0000081) | 1.87853470 |
| 128 | Lip pit (HP:0100267) | 1.86251422 |
| 129 | Abnormality of the renal cortex (HP:0011035) | 1.85348741 |
| 130 | Axonal loss (HP:0003447) | 1.82721663 |
| 131 | Abnormality of the foot musculature (HP:0001436) | 1.82597596 |
| 132 | Aortic aneurysm (HP:0004942) | 1.82052899 |
| 133 | Plagiocephaly (HP:0001357) | 1.81989892 |
| 134 | Erythema (HP:0010783) | 1.81206123 |
| 135 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.80010186 |
| 136 | Hypergammaglobulinemia (HP:0010702) | 1.79482754 |
| 137 | Vertigo (HP:0002321) | 1.79293730 |
| 138 | Corneal dystrophy (HP:0001131) | 1.77004226 |
| 139 | Chromsome breakage (HP:0040012) | 1.76354986 |
| 140 | Difficulty climbing stairs (HP:0003551) | 1.74715228 |
| 141 | Foot dorsiflexor weakness (HP:0009027) | 1.72705775 |
| 142 | Sparse eyelashes (HP:0000653) | 1.72510497 |
| 143 | Hypohidrosis (HP:0000966) | 1.71633320 |
| 144 | Nephritis (HP:0000123) | 1.71541587 |
| 145 | Skin nodule (HP:0200036) | 1.70563654 |
| 146 | Alveolar cell carcinoma (HP:0006519) | 1.70181472 |
| 147 | Mitral stenosis (HP:0001718) | 1.68416810 |
| 148 | Vertebral arch anomaly (HP:0008438) | 1.68067080 |
| 149 | Abnormality of the ischium (HP:0003174) | 1.67377716 |
| 150 | True hermaphroditism (HP:0010459) | 1.66702725 |
| 151 | Melanoma (HP:0002861) | 1.66031276 |
| 152 | Prostate neoplasm (HP:0100787) | 1.65644145 |
| 153 | Thin bony cortex (HP:0002753) | 1.65512646 |
| 154 | Proximal amyotrophy (HP:0007126) | 1.65329627 |
| 155 | Bradycardia (HP:0001662) | 1.65249503 |
| 156 | Retrobulbar optic neuritis (HP:0100654) | 1.64613002 |
| 157 | Optic neuritis (HP:0100653) | 1.64613002 |
| 158 | Bronchiectasis (HP:0002110) | 1.62435757 |
| 159 | Stomach cancer (HP:0012126) | 1.62081000 |
| 160 | Left ventricular hypertrophy (HP:0001712) | 1.62078597 |
| 161 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.62014185 |
| 162 | Hypoparathyroidism (HP:0000829) | 1.61628591 |
| 163 | Wormian bones (HP:0002645) | 1.61387107 |
| 164 | Aplasia cutis congenita (HP:0001057) | 1.59326367 |
| 165 | Muscle fiber inclusion bodies (HP:0100299) | 1.58494921 |
| 166 | Pulmonary hypertension (HP:0002092) | 1.58363245 |
| 167 | Oligohydramnios (HP:0001562) | 1.58335088 |
| 168 | Difficulty walking (HP:0002355) | 1.56643267 |
| 169 | Urticaria (HP:0001025) | 1.54129696 |
| 170 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.53810997 |
| 171 | Abnormality of the renal medulla (HP:0100957) | 1.52798172 |
| 172 | Nail dystrophy (HP:0008404) | 1.52764956 |
| 173 | Pancreatic fibrosis (HP:0100732) | 1.51620029 |
| 174 | Barrel-shaped chest (HP:0001552) | 1.51300620 |
| 175 | Hypocalcemia (HP:0002901) | 1.51256390 |
| 176 | Progressive sensorineural hearing impairment (HP:0000408) | 1.50515581 |
| 177 | Absent septum pellucidum (HP:0001331) | 1.48162805 |
| 178 | White forelock (HP:0002211) | 1.46585903 |
| 179 | Abnormality of renal excretion (HP:0011036) | 1.44704094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 8.85588897 |
| 2 | EPHA2 | 4.82709830 |
| 3 | SIK1 | 4.69709181 |
| 4 | SIK2 | 4.32939907 |
| 5 | LMTK2 | 3.70372830 |
| 6 | LATS1 | 3.40376005 |
| 7 | OBSCN | 3.19471661 |
| 8 | TTN | 2.88281894 |
| 9 | CDC42BPA | 2.83258685 |
| 10 | DMPK | 2.57048779 |
| 11 | PAK4 | 2.52165620 |
| 12 | STK38L | 2.48379000 |
| 13 | STK24 | 2.41011455 |
| 14 | MAP3K12 | 2.34810827 |
| 15 | MARK3 | 2.29353762 |
| 16 | PRPF4B | 2.02943885 |
| 17 | CASK | 1.81583616 |
| 18 | MET | 1.73418382 |
| 19 | CDK8 | 1.68575416 |
| 20 | CDK12 | 1.55595584 |
| 21 | DDR2 | 1.51454515 |
| 22 | FGFR4 | 1.50270930 |
| 23 | TIE1 | 1.46359742 |
| 24 | TAOK3 | 1.40287065 |
| 25 | MAP3K7 | 1.35421079 |
| 26 | ROCK1 | 1.31099517 |
| 27 | ADRBK2 | 1.30483734 |
| 28 | MAP3K14 | 1.29250271 |
| 29 | ICK | 1.25873838 |
| 30 | INSRR | 1.23882105 |
| 31 | TRIB3 | 1.22720783 |
| 32 | TXK | 1.21602509 |
| 33 | ERN1 | 1.16435084 |
| 34 | TBK1 | 1.16296735 |
| 35 | MARK2 | 1.12053135 |
| 36 | LATS2 | 1.10436487 |
| 37 | BMPR2 | 1.08269734 |
| 38 | MST4 | 1.07916967 |
| 39 | FGFR3 | 1.06418891 |
| 40 | SGK2 | 1.05600656 |
| 41 | PDGFRA | 1.05226210 |
| 42 | PRKD1 | 1.01053172 |
| 43 | FGFR2 | 0.99770783 |
| 44 | ZAP70 | 0.99625863 |
| 45 | TAOK1 | 0.99096246 |
| 46 | JAK1 | 0.95674003 |
| 47 | BMPR1B | 0.95556480 |
| 48 | MAPKAPK3 | 0.95433922 |
| 49 | STK3 | 0.91284269 |
| 50 | MAPK13 | 0.91248111 |
| 51 | MAP2K7 | 0.86998050 |
| 52 | MUSK | 0.86993659 |
| 53 | PHKG1 | 0.85067829 |
| 54 | PHKG2 | 0.85067829 |
| 55 | EPHB2 | 0.84218030 |
| 56 | PDK2 | 0.82687376 |
| 57 | FER | 0.80541710 |
| 58 | BLK | 0.79903291 |
| 59 | IRAK4 | 0.79704554 |
| 60 | DAPK3 | 0.79210133 |
| 61 | TEC | 0.76626631 |
| 62 | PRKAA1 | 0.76485156 |
| 63 | MKNK2 | 0.76406451 |
| 64 | CAMK1G | 0.76404228 |
| 65 | CAMK1D | 0.75459204 |
| 66 | MAPK7 | 0.75404977 |
| 67 | TLK1 | 0.73375973 |
| 68 | EPHB1 | 0.72378219 |
| 69 | PKN2 | 0.71916080 |
| 70 | MST1R | 0.71637106 |
| 71 | WNK1 | 0.70823929 |
| 72 | NLK | 0.69727500 |
| 73 | MTOR | 0.69678123 |
| 74 | TNIK | 0.66991421 |
| 75 | PAK3 | 0.65988370 |
| 76 | STK38 | 0.63741094 |
| 77 | HIPK2 | 0.63720867 |
| 78 | STK10 | 0.62462852 |
| 79 | SGK3 | 0.59840995 |
| 80 | ERBB4 | 0.59640168 |
| 81 | MAPK12 | 0.58993501 |
| 82 | PTK2 | 0.58672381 |
| 83 | EPHA3 | 0.58445223 |
| 84 | PIK3CG | 0.57826110 |
| 85 | YES1 | 0.57824167 |
| 86 | SGK494 | 0.57309754 |
| 87 | SGK223 | 0.57309754 |
| 88 | MELK | 0.57092961 |
| 89 | ZAK | 0.56784113 |
| 90 | PDPK1 | 0.56781220 |
| 91 | PRKG2 | 0.56648702 |
| 92 | EPHA4 | 0.56417312 |
| 93 | TYK2 | 0.55608156 |
| 94 | GRK1 | 0.55411329 |
| 95 | NUAK1 | 0.55029909 |
| 96 | FRK | 0.55028597 |
| 97 | CAMK1 | 0.54177829 |
| 98 | RPS6KA2 | 0.54077589 |
| 99 | BMX | 0.53714951 |
| 100 | CAMK2D | 0.53193744 |
| 101 | TAOK2 | 0.53007914 |
| 102 | STK39 | 0.52758678 |
| 103 | PDGFRB | 0.52514753 |
| 104 | MAPK15 | 0.51420861 |
| 105 | CSNK1A1L | 0.50405675 |
| 106 | PKN1 | 0.48533542 |
| 107 | TRPM7 | 0.47696136 |
| 108 | PRKCE | 0.47530165 |
| 109 | MAPK4 | 0.46860755 |
| 110 | BCR | 0.45142154 |
| 111 | CSNK1D | 0.43703818 |
| 112 | PIK3CA | 0.42666942 |
| 113 | IRAK3 | 0.42461349 |
| 114 | IKBKB | 0.41707832 |
| 115 | DAPK2 | 0.41006577 |
| 116 | IKBKE | 0.40015831 |
| 117 | JAK3 | 0.39663463 |
| 118 | MAP3K6 | 0.39388422 |
| 119 | CDK3 | 0.38854744 |
| 120 | TGFBR2 | 0.37615348 |
| 121 | CHUK | 0.33702934 |
| 122 | PRKAA2 | 0.33439505 |
| 123 | GRK7 | 0.32955953 |
| 124 | PRKCQ | 0.32574684 |
| 125 | ERBB2 | 0.32085135 |
| 126 | SRPK1 | 0.30818397 |
| 127 | MAP3K3 | 0.30619579 |
| 128 | RIPK4 | 0.29290317 |
| 129 | MAP2K4 | 0.28697245 |
| 130 | RPS6KL1 | 0.26669644 |
| 131 | RPS6KC1 | 0.26669644 |
| 132 | MAP3K5 | 0.26435975 |
| 133 | NEK6 | 0.26046020 |
| 134 | MAP2K2 | 0.25739710 |
| 135 | CAMK4 | 0.25631218 |
| 136 | RPS6KA6 | 0.25126179 |
| 137 | IRAK1 | 0.25045747 |
| 138 | MYLK | 0.24188172 |
| 139 | VRK1 | 0.22074308 |
| 140 | SGK1 | 0.21699762 |
| 141 | NEK9 | 0.20770041 |
| 142 | CSNK1G3 | 0.20343195 |
| 143 | MAP3K2 | 0.20031710 |
| 144 | MAP2K6 | 0.18873691 |
| 145 | AKT3 | 0.18409615 |
| 146 | IRAK2 | 0.17009841 |
| 147 | CSNK1G1 | 0.16542564 |
| 148 | CSNK1G2 | 0.16374428 |
| 149 | RIPK1 | 0.15655595 |
| 150 | EIF2AK2 | 0.14725520 |
| 151 | PRKG1 | 0.14684936 |
| 152 | RPS6KA4 | 0.14671032 |
| 153 | ADRBK1 | 0.13824753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.71334357 |
| 2 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.02342279 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 1.91595965 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90950204 |
| 5 | * Mineral absorption_Homo sapiens_hsa04978 | 1.89337507 |
| 6 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85987183 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 1.71367415 |
| 8 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.69127734 |
| 9 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.61477377 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.61208644 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.59311702 |
| 12 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.52722398 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 1.51472903 |
| 14 | Amoebiasis_Homo sapiens_hsa05146 | 1.48639132 |
| 15 | Axon guidance_Homo sapiens_hsa04360 | 1.47865062 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45648800 |
| 17 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.45496501 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44835444 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42880311 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39807007 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36447133 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.36351733 |
| 23 | Melanoma_Homo sapiens_hsa05218 | 1.35799338 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34882016 |
| 25 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.34212419 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31602275 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.31078910 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.30149784 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30009895 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29758500 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25895527 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.25753611 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23859684 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23810780 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21934960 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20207941 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15125000 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.13746964 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.10247908 |
| 40 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07415680 |
| 41 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.07190590 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07008347 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06724198 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05892411 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05416208 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04808707 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04694857 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.03142634 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 1.03100760 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02498496 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01502083 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.01218266 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00896302 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 1.00549424 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.99709158 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99284524 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.98223170 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98215191 |
| 59 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.97488396 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96874294 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.96626739 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.96076342 |
| 63 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.94515574 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.92912677 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.92560621 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.89817793 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89269174 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88925196 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88042309 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.87266823 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85765346 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.85736576 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85568666 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85445711 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82938001 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82821408 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81278243 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80716577 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.80656343 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80609533 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.79222284 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78342649 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.77964423 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77739572 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76984244 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76433346 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76416193 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75531367 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74978658 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74197971 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.73330141 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72862603 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72776880 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.72062829 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71308176 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.71108462 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70153055 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70013270 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68389012 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66417512 |
| 101 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65633220 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63207858 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63058634 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.62094716 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61150106 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.60556916 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60229305 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59879289 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.59344565 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59223281 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58385000 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.58009591 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57427795 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56506572 |
| 115 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56486207 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.54213517 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54040708 |
| 118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53492252 |
| 119 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53199379 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52671925 |
| 121 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50423587 |
| 122 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50390276 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50260436 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50221514 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49551481 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.49365987 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48762533 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48687700 |
| 129 | Long-term depression_Homo sapiens_hsa04730 | 0.48346317 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48271495 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48197248 |
| 132 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48005045 |
| 133 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47954777 |
| 134 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47727485 |
| 135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47588441 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47207482 |
| 137 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46500526 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46133419 |
| 139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45594259 |
| 140 | Insulin secretion_Homo sapiens_hsa04911 | 0.45459938 |
| 141 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45202920 |
| 142 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45105211 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44256434 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41734102 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41719062 |

